HECHT BETH (See Remarks) sold 1.4% of their position (16.67K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $133.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/4/2026ACC: 0001652410-26-000016
Officer· See Remarks
Since Oct 2021
-16.67K
Net shares
Net seller
$133.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
16.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−16.67K
Price / share
$8.01
Trade value
$133.55K
% of position
1.4%
8/3/2026
1.16M→1.14M
Total
Net shares
−16.67K
Net value
-$133.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | S · Sale | −16.67K | $8.01 | $133.55K | 1.4% | 1.16M | 1.14M |
| Total | −16.67K | -$133.55K | ||||||
Derivative Transactions0
No derivative transactions reported